Bevacizumab - Avastin; vascular endothelial growth factor monoclonal antibody, recombinant -- Product Record

VEGF Mab, rDNA

    Nomenclature:
      VEGF Mab, rDNA [BIO]
      Avastin [TR]
      bevacizumab [FDA USAN INN]
      immunoglobulin G1, anti-(human vascular endothelial growth factor) (human-mouse monoclonal rhuMAb-VEGF .gamma.1-chain), disulfide with human-mouse monoclonal rhuMAb-VEGF light chain, dimer [CAS]
      216974-75-3 [CAS RN]
      anti-VEGF monoclonal antibody [SY]
      rhuMAb-VEGF [SY]
      vascular endothelial growth factor monoclonal antibody, recombinant [SY]
      NDC 50242-060-01 and NDC 50242-060-02 [NDC]

    molecular weight (kDa) = 149

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 2004